Virtual screening and lead optimisation to identify novel inhibitors for   HDAC-8
  Histone deacetylase (HDAC) and Histone acetyl-transferase (HAT) are enzymes that influence transcription by selectively deacetylating or acetylating the (epsilon)-amino groups of lysine located near the amino termini of core histone proteins. Over expression of HDACs noted in many forms of cancers including leukemia and breast cancer. HDAC inhibitors have been shown to be potent inducers of growth arrest, differentiation, and/or apoptotic cell death. There is a growing interest in the development of histone deacetylase inhibitors as anti cancer agents. Three known ligands of HDAC-8 were taken and docked. The best scores were analyzed and structures similar to these ligands were downloaded using carol and corina databases and docked. Also large databases of small molecules were computationally screened using molecular docking for hits that can conformationally and chemically fit to the active site. Molecules which got high scores for both GoldScore and ChemScore were selected and compared with the previous results. Those with best results were then taken for calculating H-bond interactions and close contacts. Bioactivity prediction of the best ranked ligands was done. Their physicochemical properties were also analyzed. Four new molecules were identified and suggested for further testing in the wet lab. 
Maria Antony Dhivyan JE and Anoop MN
q-bio.BM q-bio.GN